Institutional Ownership Sensei Biotherapeutics, Inc. (SNSE)
This table provides information about the institutional ownership of Sensei Biotherapeutics, Inc. (SNSE). We have compiled data on the 23 institutions that hold shares in the stock, with a total of 1.97 Million shares, which have been reported (via 13F filing form) to have a value of $591,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
585,576
shares
|
$181,528
0.0% of portfolio
|
Q1 2025
Reduced 1.49%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
449,963
shares
|
$139,488
0.02% of portfolio
|
Q1 2025
Reduced 30.77%
|
|
|
Catalio Capital Management, LP
New York, NY |
May 15, 2025 Q1 2025 |
294,374
shares
|
$91,255
0.03% of portfolio
|
Q4 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
177,300
shares
|
$54,963
0.0% of portfolio
|
Q1 2025
Added 13.07%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
150,709
shares
|
$46,719
0.0% of portfolio
|
Q1 2025
Added 1.22%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
108,658
shares
|
$33,683
0.0% of portfolio
|
Q1 2025
Reduced 37.12%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
42,541
shares
|
$13,187
0.0% of portfolio
|
Q1 2025
Added 2126950.0%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
25,983
shares
|
$8,054
0.0% of portfolio
|
Q2 2024
Reduced 0.25%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
25,774
shares
|
$7,989
0.0% of portfolio
|
Q2 2022
Reduced 88.57%
|
|
|
Raymond James & Associates
St Petersburg, FL |
Oct 18, 2024 Q3 2024 |
20,000
shares
|
$6,200
0.0% of portfolio
|
Q3 2024
Added 42.86%
|
|
|
Cresset Asset Management, LLC
Chicago, IL |
May 13, 2025 Q1 2025 |
19,671
shares
|
$6,098
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Nwf Advisory Services Inc.
Los Angeles, CA |
May 14, 2025 Q4 2024 |
16,514
shares
|
$5,119
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Leo Brokerage, LLC
|
Jul 25, 2023 Q2 2023 |
14,845
shares
|
$4,601
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
May 13, 2025 Q1 2025 |
14,000
shares
|
$4,340
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
9,219
shares
|
$2,857
0.0% of portfolio
|
Q2 2024
Added 32.54%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,777
shares
|
$2,410
0.0% of portfolio
|
Q2 2024
Reduced 76.84%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2025 Q1 2025 |
5,404
shares
|
$1,675
0.0% of portfolio
|
Q1 2025
Reduced 0.81%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
2,558
shares
|
$792
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
702
shares
|
$217
0.0% of portfolio
|
Q1 2025
Reduced 0.43%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
142
shares
|
$44
0.0% of portfolio
|
Q1 2025
Added 4.41%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
124
shares
|
$38
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
92
shares
|
$28
0.0% of portfolio
|
Q1 2025
Added 29.58%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|